PhilipMagnusGrantMD

Infectious Disease • Stanford, CA

Instructor, Medicine - Infectious Diseases, Stanford University Medical Center

Join to view full profile

Are you Dr. Grant?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Fax+1 650-725-6908

Summary

Dr. Philip Grant, MD is an infectious disease specialist in Stanford, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care and is an Instructor at Stanford University Medical Center.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2006 - 2008
University of WashingtonResidency, Internal Medicine, 2000 - 2003
University of California San Francisco School of MedicineClass of 2000

Certifications & Licensure

CA State Medical License 2006 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Stanford Universities: The Stanford HIV Aging Cohort Start of enrollment: 2010 Dec 01
Completed
Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study") Start of enrollment: 2013 Dec 01
Completed
Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood Start of enrollment: 2019 Apr 15
Withdrawn
Phase 4
Response to Influenza Vaccine During Pregnancy Start of enrollment: 2019 Sep 30
Completed
Phase 1
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood Start of enrollment: 2019 Apr 11
Withdrawn
Phase 4
The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets Start of enrollment: 2019 Oct 08
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

49 citations
Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
Sabina S. Alistar, Philip M. Grant, Eran Bendavid
BMC Medicine. 2014-03-17
94 citations
Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: ...
Karen B. Jacobson, Mallika Rao, Hector Bonilla, Aruna Subramanian, Isabelle Hack
Clinical Infectious Diseases. 2021-08-02
184 citations
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Jennifer G. Wilson, Laura J. Simpson, Anne-Maud Ferreira, Arjun Rustagi, Jonasel Roque
JCI Insight. 2020-09-03

Press Mentions

New HIV Preventive Strategy Sparks Excitement — and Protests — at AIDS ConferenceJuly 24th, 2024
Do COVID Vaccines Work Against Omicron? What We Know so FarNovember 29th, 2021
Despite New Study, Stanford Doctor Explains Why J&J Vaccine Is Still EffectiveJuly 21st, 2021
Join now to see all